AlphaStocks

AZN vs MTH

ASTRAZENECA PLC vs Meritage Homes CORP — Side-by-Side Stock Comparison

AZN

ASTRAZENECA PLC

8.4

Strong Buy

$200.99

MTH

Meritage Homes CORP

4.5

Weak

$62.10

AZN vs MTH: Which is the Better Investment?

ASTRAZENECA PLC (AZN) scores 8.4/10 while Meritage Homes CORP (MTH) scores 4.5/10 on AlphaStocks' composite model. ASTRAZENECA PLC has the higher composite rating of Strong Buy. On a P/E basis, Meritage Homes CORP trades at 9.8x, making it the more attractively priced of the two.

This comparison is algorithmically generated and is not financial advice.

MetricAZNMTH
Scores & Fundamentals
Composite Score8.4/104.5/10
RatingStrong BuyWeak
Price$200.99$62.10
P/E Ratio30.49.8
ROE21.9%8.6%
Market Cap$312B$4B
Fair Value$192.63
Dividend Yield1.6%2.8%
Sector Rank#3 of 1127#727 of 1127
Model Verdicts
PiotroskiStrongNeutral
BuffettStrongAttractive
GrahamCautionAttractive
LynchNeutralAttractive
GreenblattNeutralNeutral
View full AZNanalysis →View full MTHanalysis →
Compare any two stocks →

AZN vs MTH: Which Stock Scores Higher?

ASTRAZENECA PLC (AZN) and Meritage Homes CORP (MTH) are among the most compared stocks in the S&P 500. AZN currently leads with a composite score of 8.4/10 (Strong Buy) compared to MTH's 4.5/10 (Weak).

The AlphaStocks composite score evaluates each stock across four dimensions: Quality (business strength measured by Piotroski F-Score and Buffett quality criteria), Value (discount to intrinsic worth using Graham, Lynch, and Greenblatt models), Momentum (6-month price trend), and Timing (a confirmation signal that requires both value and momentum to align). A higher composite score indicates stronger overall fundamentals combined with favorable market conditions.

This comparison uses the same scoring framework for both companies, ensuring an apples-to-apples evaluation. Scores are recalculated daily after market close using data from SEC filings and market prices. Read the full methodology to understand how each model contributes to the composite score.

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer